Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
368.94B
Market cap368.94B
Price-Earnings ratio
152.70
Price-Earnings ratio152.70
Dividend yield
2.27%
Dividend yield2.27%
Average volume
11.30M
Average volume11.30M
High today
$151.35
High today$151.35
Low today
$147.43
Low today$147.43
Open price
$149.64
Open price$149.64
Volume
12.34M
Volume12.34M
52 Week high
$156.92
52 Week high$156.92
52 Week low
$82.01
52 Week low$82.01

Stock Snapshot

With a market cap of 368.94B, Merck(MRK) trades at $149.65. The stock has a price-to-earnings ratio of 152.70 and currently yields dividends of 2.27%.

As of 2026-11-01, Merck(MRK) stock has fluctuated between $147.43 and $151.35. The current price stands at $149.65, placing the stock +1.5% above today's low and -1.1% off the high.

The Merck(MRK)'s current trading volume is 12.34M, compared to an average daily volume of 11.3M.

During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.

During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.

MRK News

Simply Wall St 19h
Merck Stock Still Looks Like A Bargain On Its 113% Run

has been a strong performer in recent years, and with fresh oncology data and new treatments moving through regulators, the question now is whether the current...

TipRanks 2d
Merck & Co. Earnings Call Signals Pipeline-Powered Growth

Merck & Company ((MRK)) has held its Q3 earnings call. Read on for the main highlights of the call. Merck & Co.’s latest earnings call struck a distinctly upbe...

The Motley Fool 2d
Why Merck Stock Flew Higher on Friday

The positive sentiment engendered by Merck's (MRK +2.18%) solid third-quarter results posted on Thursday carried over into the following trading session. It was...

Why Merck Stock Flew Higher on Friday

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
29%
Sell
3.2%

More MRK News

Benzinga 2d
Merck One of Top Large-Cap Biopharma Picks-Analyst

Merck & Co. Inc. (NYSE:MRK) shares were trading higher on Friday on a continued rally on better-than-expected third-quarter earnings and upbeat fiscal 2026 guid...

Merck One of Top Large-Cap Biopharma Picks-Analyst
MarketWatch 2d
The big winners of the tech wreck are biopharma stocks

Who would have believed that the boring healthcare industry would be the hottest stock sector of 2026? Companies like Johnson & Johnson JNJ, Quest Diagnostics...

The big winners of the tech wreck are biopharma stocks
Simply Wall St 2d
Merck Raised 2026 Guidance, Is It Still 8% Undervalued?

Merck (MRK) is back in focus after third quarter results topped analyst forecasts and management raised full year 2026 sales and profit guidance, supported by o...

24/7 Wall St. 2d
$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends

Investing $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends Dividends keep paying whether you sell or not, and four health...

$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
Benzinga 3d
Merck's Keytruda Franchise Expands, Signals 'Modest' Revenue Growth in 2027

Merck & Co. Inc. (NYSE:MRK) stock edged higher Thursday after the drugmaker reported third-quarter results that topped Wall Street revenue expectations and upbe...

Merck's Keytruda Franchise Expands, Signals 'Modest' Revenue Growth in 2027
24/7 Wall St. 3d
Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher

Investing Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher Merck (NYSE:MRK | MRK Price Prediction) is t...

Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher
TipRanks 3d
Merck Stock Rises 2% on $830 Million Keytruda Sales Beat Q3 Forecasts and Higher Full-Year Profit Outlook

Merck & Co (MRK) shares rose 2.14% in Thursday premarket trading after the drugmaker beat third-quarter Wall Street estimates and raised its full-year adjusted...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.